← FDA DRUG APPROVALS

FDA ANDA · ANDA086760

PHYLLOCONTIN

Sponsor: PHARM RES ASSOC

APPLICATION
ANDA086760
TYPE
ANDA
ORIGINAL APPROVAL
1979-11-21
LATEST ACTION
1997-03-03
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

PHYLLOCONTINDiscontinued
AMINOPHYLLINE 225MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

1997-03-03Labeling · Supplement 12AP
1996-03-06Labeling · Supplement 11AP
1991-08-16Labeling · Supplement 6AP
1979-11-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →